CVRX CVRx, Inc. - Common Stock
$2,73
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 6, 2026
52W-Spanne
$2–$11
6% of range
Analystenbewertung
BUY
13 analysts
Kursziel
$6
+116% upside
P/E (TTM)
-1.3
ROE
-109.6%
Nettogewinnmarge
-94.1%
Über CVRx, Inc. - Common Stock Unternehmensübersicht von Wikipedia
CVRX Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$2.73
Marktkapitalisierung
$72M
P/E (TTM)
-1.3
EPS (TTM)
$-2.04
Umsatz (TTM)
$57M
Dividendenrendite
—
ROE
-109.6%
Verschuldungsgrad
1.3
52W-Spanne
$2 – $11
CVRX Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$57M
2020-12-31
→
2025-12-31
EPS
$-2.04
2021-12-31
→
2025-12-31
Freier Cashflow
$-41M
2021-12-31
→
2025-12-31
Margen
-94.1%
2021-12-31
→
2025-12-31
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
CVRX
Peer-Median
P/E (TTM)
-1.3
27.5
P/S (TTM) (K/V (TTM))
1.3
2.8
P/B (K/B)
1.8
4.5
EV / EBITDA
-0.9
—
Price / FCF (Kurs / FCF)
-1.8
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
CVRX
Peer-Median
Gross Margin (Bruttogewinnmarge)
85.3%
59.5%
Operating Margin (Betriebsgewinnmarge)
-90.5%
—
Net Profit Margin (Nettogewinnmarge)
-94.1%
-21.3%
ROA
-44.8%
-19.0%
ROE
-109.6%
-25.2%
ROIC
-57.7%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
CVRX
Peer-Median
Debt / Equity (Fremdkapital / Eigenkapital)
1.3
—
Current Ratio (Liquiditätsgrad)
7.6
2.9
Quick Ratio
6.5
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
CVRX
Peer-Median
Revenue YoY (Umsatz YoY)
10.4%
—
Revenue CAGR 3Y (Umsatz CAGR 3J)
36.1%
—
Revenue CAGR 5Y (Umsatz CAGR 5J)
56.4%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
CVRX
Peer-Median
CVRX Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
13 Analysten
- Starker Kauf 3 23,1%
- Kauf 8 61,5%
- Halten 1 7,7%
- Verkauf 1 7,7%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
6 Analysten · 2026-08-15
Median
$4.50
Mittelwert
$5.92
← Unter allen Zielen
$2.73
Tief
$3.50
Hoch
$13.00
Median-Ziel
$4.50
+64,6%
Mittelwert-Ziel
$5.92
+116,4%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.01%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-0.53 | $-0.53 | 0.00% |
| 31. März 2026 | $-0.50 | $-0.51 | 0.01% |
| 31. Dezember 2025 | $-0.46 | $-0.45 | -0.01% |
| 30. September 2025 | $-0.49 | $-0.51 | 0.02% |
| 30. Juni 2025 | $-0.57 | $-0.53 | -0.04% |
| 31. März 2025 | $-0.53 | $-0.58 | 0.05% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| CVRX | $187M | -3.5 | 10.4% | -94.1% | -109.6% | 85.3% |
| OM | $67M | -0.7 | 5.1% | -68.3% | -58.0% | 39.1% |
| VANI | $94M | -2.9 | — | — | -257.8% | — |
| ODYS | $54M | -3.1 | -23.9% | -565.0% | -58.7% | 28.9% |
| DXR | — | — | — | — | — | — |
| COCH | — | — | — | — | — | — |
| MDAI | — | — | — | — | — | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 17
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $57M | $51M | $39M | $22M | $13M | $6M | |
| Cost of Revenue | $8M | $8M | $6M | $5M | $4M | $1M | |
| Gross Profit | $48M | $43M | $33M | $17M | $9M | $5M | |
| R&D Expense | $11M | $11M | $12M | $10M | $8M | $6M | |
| SG&A Expense | $88M | $91M | $65M | $50M | $28M | $10M | |
| Operating Expenses | $100M | $102M | $76M | $60M | $35M | $16M | |
| Operating Income | $-51M | $-59M | $-43M | $-43M | $-26M | $-12M | |
| Interest Expense | · | · | $2M | $165.0K | $2M | $2M | |
| Other Non-op | $4M | $4M | $4M | $1M | $-15M | $-40.0K | |
| Pretax Income | $-53M | $-60M | $-41M | $-41M | $-43M | $-14M | |
| Income Tax | $-18.0K | $55.0K | $147.0K | $109.0K | $91.0K | $85.0K | |
| Net Income | $-53M | $-60M | $-41M | $-41M | $-43M | $-14M | |
| EPS (Basic) | $-2.04 | $-2.65 | $-1.99 | $-2.02 | $-4.16 | · | |
| EPS (Diluted) | $-2.04 | $-2.65 | $-1.99 | $-2.02 | $-4.16 | · | |
| Shares (Basic) | 26,084,709 | 22,596,229 | 20,754,375 | 20,532,838 | 10,360,054 | · | |
| Shares (Diluted) | 26,084,709 | 22,596,229 | 20,754,375 | 20,532,838 | 10,360,054 | · | |
| EBITDA | $-51M | $-59M | $-43M | $-43M | $-26M | · |
Bilanz 24
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $76M | $106M | $91M | $106M | $142M | $59M | |
| Receivables | $11M | $9M | $8M | $6M | $3M | $1M | |
| Inventory | $12M | $12M | $11M | $7M | $4M | $3M | |
| Prepaid Expense | $3M | $3M | $3M | $4M | $3M | $605.0K | |
| Current Assets | $102M | $130M | $112M | $123M | $151M | $64M | |
| PP&E (Net) | $2M | $3M | $2M | $2M | $1M | $410.0K | |
| PP&E (Gross) | $6M | $6M | $5M | $4M | $3M | $2M | |
| Accum. Depreciation | $4M | $3M | $3M | $2M | $2M | $2M | |
| Other Non-current Assets | $26.0K | $27.0K | $27.0K | $27.0K | $26.0K | $26.0K | |
| Total Assets | $105M | $133M | $115M | $125M | $153M | $65M | |
| Accounts Payable | $4M | $3M | $2M | $2M | $510.0K | $483.0K | |
| Accrued Liabilities | $9M | $8M | $6M | $6M | $5M | $4M | |
| Current Liabilities | $13M | $11M | $8M | $8M | $6M | $8M | |
| Capital Leases | $638.0K | $877.0K | $1M | $117.0K | $0 | · | |
| Other Non-current Liabilities | $2M | $1M | $1M | $805.0K | $681.0K | $777.0K | |
| Total Liabilities | $65M | $62M | $39M | $16M | $7M | $28M | |
| Long-term Debt | · | · | · | · | · | $19M | |
| Total Debt | $50M | $49M | $29M | $7M | $0 | · | |
| Common Stock | $263.0K | $253.0K | $209.0K | $207.0K | $204.0K | $4.0K | |
| Retained Earnings | $-591M | $-537M | $-477M | $-436M | $-395M | $-352M | |
| AOCI | $-203.0K | $-206.0K | $-207.0K | $-207.0K | $-198.0K | $-190.0K | |
| Stockholders' Equity | $39M | $71M | $76M | $109M | $146M | $-293M | |
| Liabilities + Equity | $105M | $133M | $115M | $125M | $153M | $65M | |
| Shares Outstanding | 26,311,607 | 25,324,684 | 20,879,199 | 20,663,736 | 20,399,337 | 360,412 |
Cashflow 11
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $11M | $19M | $6M | $4M | $2M | $132.0K | |
| Operating Cash Flow | $-40M | $-39M | $-39M | $-43M | $-28M | $-16M | |
| CapEx | $580.0K | $1M | $591.0K | $685.0K | $1M | $311.0K | |
| Investing Cash Flow | $-580.0K | $-1M | $-591.0K | $-685.0K | $-1M | $-311.0K | |
| Net Debt Issued | · | · | · | $0 | $-21M | · | |
| Stock Issued | $9M | $33M | $0 | $0 | $133M | $0 | |
| Net Stock Activity | $9M | $33M | · | $0 | $133M | · | |
| Financing Cash Flow | $11M | $56M | $24M | $7M | $112M | $50M | |
| Net Change in Cash | $-30M | $15M | $-16M | $-36M | $83M | $33M | |
| Free Cash Flow | $-41M | $-41M | $-40M | $-43M | $-29M | · | |
| Levered FCF | · | · | $-41M | $-44M | $-31M | · |
Rentabilität 8
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 85.3% | 83.8% | 84.1% | 77.8% | 72.1% | · | |
| Operating Margin | -90.5% | -116.0% | -109.7% | -189.3% | -199.2% | · | |
| Net Margin | -94.1% | -116.9% | -104.8% | -184.4% | -330.4% | · | |
| Pretax Margin | -94.1% | -116.8% | -104.5% | -183.9% | -329.8% | · | |
| EBITDA Margin | -90.5% | -116.0% | -109.7% | -189.3% | -199.2% | · | |
| ROA | -44.8% | -48.2% | -34.3% | -29.9% | -39.6% | · | |
| ROE | -109.6% | -88.0% | -51.9% | -36.4% | -28.5% | · | |
| ROIC | -57.7% | -49.5% | -41.1% | -36.8% | -17.8% | · |
Liquidität & Solvenz 5
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 7.6 | 12.1 | 14.3 | 15.2 | 25.6 | · | |
| Quick Ratio | 6.5 | 10.7 | 12.5 | 13.8 | 24.5 | · | |
| Debt / Equity | 1.3 | 0.7 | 0.4 | 0.1 | 0.0 | · | |
| LT Debt / Equity | 1.3 | 0.7 | 0.4 | 0.1 | 0.0 | · | |
| Interest Coverage | · | · | -24.0 | -257.7 | -11.7 | · |
Effizienz 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.4 | 0.3 | 0.2 | 0.1 | · | |
| Inventory Turnover | 0.7 | 0.7 | 0.7 | 0.9 | 1.0 | · | |
| Receivables Turnover | 5.7 | 6.1 | 6.0 | 5.6 | 6.8 | · |
Wachstumsraten 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 10.4% | 30.5% | 74.9% | 72.4% | 115.4% | · | |
| Revenue CAGR 3Y | 36.1% | 57.9% | 86.6% | · | · | · | |
| Revenue CAGR 5Y | 56.4% | · | · | · | · | · |
Bewertung (TTM) 14
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $57M | $51M | $39M | $22M | $13M | · | |
| Net Income TTM | $-53M | $-60M | $-41M | $-41M | $-43M | · | |
| Market Cap | $187M | $321M | $656M | $379M | $249M | · | |
| Enterprise Value | $161M | $264M | $595M | $279M | $107M | · | |
| P/E | -3.5 | -4.8 | -15.8 | -9.1 | -2.9 | · | |
| P/S | 3.3 | 6.3 | 16.7 | 16.9 | 19.1 | · | |
| P/B | 4.8 | 4.5 | 8.6 | 3.5 | 1.7 | · | |
| P / Tangible Book | 4.8 | 4.5 | 8.6 | 3.5 | 1.7 | · | |
| P / Cash Flow | -4.7 | -8.2 | -16.8 | -8.9 | -9.0 | · | |
| P / FCF | -4.6 | -7.9 | -16.6 | -8.7 | -8.6 | · | |
| EV / EBITDA | -3.1 | -4.4 | -13.8 | -6.6 | -4.1 | · | |
| EV / FCF | -3.9 | -6.5 | -15.0 | -6.4 | -3.7 | · | |
| EV / Revenue | 2.8 | 5.2 | 15.1 | 12.4 | 8.2 | · | |
| Earnings Yield | -28.7% | -20.9% | -6.3% | -11.0% | -34.0% | · |
Gewinn- und Verlustrechnung 17
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $16M | $15M | $16M | $15M | $14M | $12M | $15M | $13M | $12M | $11M | $11M | $11M | $10M | $8M | $7M | $6M | |
| Cost of Revenue | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $2M | $1M | |
| Gross Profit | $14M | $13M | $14M | $13M | $11M | $10M | $13M | $11M | $10M | $9M | $10M | $9M | $8M | $7M | $6M | $5M | |
| R&D Expense | $3M | $3M | $3M | $3M | $2M | $3M | $3M | $3M | $3M | $3M | $2M | $3M | $3M | $3M | $3M | $2M | |
| SG&A Expense | $24M | $22M | $22M | $22M | $23M | $21M | $20M | $22M | $21M | $28M | $17M | $16M | $16M | $15M | $14M | $13M | |
| Operating Expenses | $27M | $25M | $25M | $25M | $26M | $24M | $23M | $24M | $24M | $31M | $19M | $18M | $20M | $19M | $17M | $15M | |
| Operating Income | $-13M | $-12M | $-11M | $-12M | $-14M | $-13M | $-10M | $-13M | $-14M | $-22M | $-10M | $-10M | $-12M | $-12M | $-11M | $-10M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $960.0K | · | $499.0K | $481.0K | $240.0K | $165.0K | $0 | |
| Other Non-op | $560.0K | $593.0K | $660.0K | $875.0K | $1M | $1M | $1M | $917.0K | $944.0K | $1M | $1M | $1M | $616.0K | $1M | $1M | $328.0K | |
| Pretax Income | $-14M | $-13M | $-12M | $-13M | $-15M | $-14M | $-11M | $-13M | $-14M | $-22M | $-9M | $-9M | $-12M | $-11M | $-11M | $-10M | |
| Income Tax | $3.0K | $1.0K | $-7.0K | $-3.0K | $-3.0K | $-5.0K | $-71.0K | $47.0K | $41.0K | $38.0K | $39.0K | $40.0K | $34.0K | $34.0K | $28.0K | $32.0K | |
| Net Income | $-14M | $-13M | $-12M | $-13M | $-15M | $-14M | $-11M | $-13M | $-14M | $-22M | $-9M | $-9M | $-12M | $-11M | $-11M | $-10M | |
| EPS (Basic) | $-0.53 | $-0.50 | $-0.45 | $-0.49 | $-0.57 | $-0.53 | $-0.39 | $-0.57 | $-0.65 | $-1.04 | $-0.45 | $-0.43 | $-0.56 | $-0.55 | $-0.51 | $-0.48 | |
| EPS (Diluted) | $-0.53 | $-0.50 | $-0.45 | $-0.49 | $-0.57 | $-0.53 | $-0.39 | $-0.57 | $-0.65 | $-1.04 | $-0.45 | $-0.43 | $-0.56 | $-0.55 | $-0.51 | $-0.48 | |
| Shares (Basic) | 26,515,442 | 26,355,591 | -52,031,231 | 26,168,562 | 26,071,316 | 25,876,062 | -43,047,659 | 22,783,337 | 21,628,542 | 21,232,009 | -41,452,049 | 20,801,350 | 20,711,850 | 20,693,224 | -41,002,569 | 20,576,838 | |
| Shares (Diluted) | 26,515,442 | 26,355,591 | -52,031,231 | 26,168,562 | 26,071,316 | 25,876,062 | -43,047,659 | 22,783,337 | 21,628,542 | 21,232,009 | -41,452,049 | 20,801,350 | 20,711,850 | 20,693,224 | -41,002,569 | 20,576,838 | |
| EBITDA | $-13M | $-12M | · | $-12M | $-14M | $-13M | · | $-13M | $-14M | $-22M | · | $-10M | $-12M | $-12M | · | $-10M |
Bilanz 23
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $65M | $72M | $76M | $85M | $95M | $103M | $106M | $100M | $70M | $80M | $91M | $83M | $91M | $103M | $106M | $110M | |
| Receivables | $9M | $9M | $11M | $8M | $7M | $9M | $9M | $9M | $9M | $8M | $8M | $6M | $7M | $6M | $6M | $5M | |
| Inventory | $13M | $12M | $12M | $11M | $12M | $12M | $12M | $12M | $11M | $11M | $11M | $11M | $11M | $8M | $7M | $6M | |
| Prepaid Expense | $2M | $3M | $3M | $3M | $2M | $3M | $3M | $3M | $2M | $3M | $3M | $3M | $4M | $3M | $4M | $3M | |
| Current Assets | $89M | $97M | $102M | $108M | $116M | $126M | $130M | $124M | $92M | $102M | $112M | $104M | $112M | $121M | $123M | $124M | |
| PP&E (Net) | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | |
| PP&E (Gross) | $5M | $5M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $5M | $5M | $4M | $4M | $4M | $4M | $4M | |
| Accum. Depreciation | $3M | $3M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | |
| Other Non-current Assets | $26.0K | $26.0K | $26.0K | $26.0K | $26.0K | $26.0K | $27.0K | $26.0K | $26.0K | $26.0K | $27.0K | $26.0K | $27.0K | $27.0K | $27.0K | $26.0K | |
| Total Assets | $92M | $100M | $105M | $111M | $120M | $130M | $133M | $128M | $96M | $106M | $115M | $106M | $115M | $123M | $125M | $127M | |
| Accounts Payable | $4M | $3M | $4M | $4M | $3M | $3M | $3M | $3M | $4M | $3M | $2M | $1M | $3M | $2M | $2M | $1M | |
| Accrued Liabilities | $7M | $6M | $9M | $8M | $7M | $6M | $8M | $8M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | |
| Current Liabilities | $11M | $9M | $13M | $11M | $10M | $9M | $11M | $11M | $9M | $8M | $8M | $7M | $9M | $8M | $8M | $7M | |
| Capital Leases | $448.0K | $544.0K | $638.0K | $730.0K | $819.0K | $802.0K | $877.0K | $951.0K | $1M | $1M | $1M | $916.0K | $946.0K | $59.0K | $117.0K | $175.0K | |
| Other Non-current Liabilities | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $960.0K | $885.0K | $815.0K | $805.0K | $761.0K | |
| Total Liabilities | $72M | $71M | $65M | $63M | $62M | $60M | $62M | $62M | $41M | $40M | $39M | $24M | $25M | $23M | $16M | $8M | |
| Total Debt | $59M | $58M | · | $49M | $49M | $49M | · | $49M | $29M | $29M | · | $14M | $14M | $14M | · | · | |
| Common Stock | $266.0K | $264.0K | $263.0K | $262.0K | $261.0K | $261.0K | $253.0K | $242.0K | $217.0K | $216.0K | $209.0K | $208.0K | $208.0K | $207.0K | $207.0K | $206.0K | |
| Retained Earnings | $-618M | $-604M | $-591M | $-579M | $-566M | $-551M | $-537M | $-527M | $-514M | $-500M | $-477M | $-468M | $-459M | $-448M | $-436M | $-426M | |
| AOCI | $-204.0K | $-203.0K | $-203.0K | $-204.0K | $-203.0K | $-205.0K | $-206.0K | $-208.0K | $-210.0K | $-210.0K | $-207.0K | $-208.0K | $-187.0K | $-204.0K | $-207.0K | $-219.0K | |
| Stockholders' Equity | $20M | $29M | $39M | $48M | $58M | $69M | $71M | $65M | $55M | $66M | $76M | $83M | $90M | $100M | $109M | $118M | |
| Liabilities + Equity | $92M | $100M | $105M | $111M | $120M | $130M | $133M | $128M | $96M | $106M | $115M | $106M | $115M | $123M | $125M | $127M | |
| Shares Outstanding | 26,641,597 | 26,428,767 | 26,311,607 | 26,193,733 | 26,145,951 | 26,051,992 | 25,324,684 | 24,203,658 | 21,712,357 | 21,593,173 | 20,879,199 | 20,813,612 | 20,750,910 | 20,708,940 | 20,663,736 | 20,578,963 |
Cashflow 10
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $4M | $3M | $3M | $3M | $3M | $2M | $3M | $3M | $3M | $11M | $2M | $2M | $1M | $2M | $1M | $929.0K | |
| Operating Cash Flow | $-9M | $-12M | $-10M | $-10M | $-8M | $-13M | $-8M | $-10M | $-10M | $-11M | $-8M | $-8M | $-13M | $-10M | $-11M | $-11M | |
| CapEx | $112.0K | $122.0K | $68.0K | $295.0K | $103.0K | $114.0K | $52.0K | $37.0K | $355.0K | $917.0K | $169.0K | $39.0K | $143.0K | $240.0K | $79.0K | $264.0K | |
| Investing Cash Flow | $-112.0K | $-122.0K | $-68.0K | $-295.0K | $-103.0K | $-114.0K | $-52.0K | $-37.0K | $-355.0K | $-917.0K | $-169.0K | $-39.0K | $-143.0K | $-240.0K | $-79.0K | $-264.0K | |
| Stock Issued | $739.0K | $-43.0K | $-179.0K | $-45.0K | $0 | $9M | $12M | $20M | $-1.0K | $547.0K | $0 | $0 | $0 | $0 | · | · | |
| Net Stock Activity | · | $-43.0K | · | · | · | $9M | · | · | · | $547.0K | · | · | · | · | · | · | |
| Financing Cash Flow | $1M | $9M | $410.0K | $103.0K | $392.0K | $10M | $14M | $40M | $472.0K | $1M | $16M | $363.0K | $473.0K | $8M | $7M | $7.0K | |
| Net Change in Cash | $-8M | $-3M | $-9M | $-10M | $-8M | $-3M | $6M | $30M | $-10M | $-10M | $8M | $-8M | $-12M | $-3M | $-4M | $-11M | |
| Free Cash Flow | · | $-12M | · | · | · | $-13M | · | · | · | $-12M | · | · | · | $-10M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-13M | · | · | · | $-11M | · | · |
Rentabilität 8
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 87.4% | 87.2% | · | 86.8% | 84.3% | 83.5% | · | 83.2% | 83.9% | 85.0% | · | 83.9% | 84.0% | 83.4% | · | 78.3% | |
| Operating Margin | -82.9% | -82.3% | · | -83.5% | -105.8% | -108.8% | · | -97.3% | -118.3% | -206.4% | · | -90.6% | -123.7% | -152.4% | · | -163.7% | |
| Net Margin | -89.4% | -88.8% | · | -87.6% | -108.4% | -111.5% | · | -98.0% | -118.8% | -206.0% | · | -85.7% | -122.6% | -142.6% | · | -158.9% | |
| Pretax Margin | -89.4% | -88.8% | · | -87.6% | -108.5% | -111.5% | · | -97.6% | -118.5% | -205.7% | · | -85.4% | -122.3% | -142.1% | · | -158.4% | |
| EBITDA Margin | -82.9% | -82.3% | · | -83.5% | -105.8% | -108.8% | · | -97.3% | -118.3% | -206.4% | · | -90.6% | -123.7% | -152.4% | · | -163.7% | |
| ROA | -13.3% | -11.4% | · | -10.8% | -13.7% | -11.7% | · | -11.2% | -13.3% | -19.4% | · | -7.7% | -9.4% | -8.5% | · | -6.4% | |
| ROE | -36.1% | -26.7% | · | -22.7% | -26.0% | -20.3% | · | -17.7% | -19.3% | -26.8% | · | -9.0% | -10.7% | -9.6% | · | -7.2% | |
| ROIC | -16.6% | -13.9% | · | -12.6% | -13.4% | -11.3% | · | -11.4% | -16.6% | -23.3% | · | -9.8% | -11.3% | -10.7% | · | -8.6% |
Liquidität & Solvenz 5
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.0 | 10.2 | · | 9.6 | 12.0 | 14.8 | · | 11.3 | 10.1 | 12.2 | · | 14.0 | 12.6 | 15.2 | · | 16.8 | |
| Quick Ratio | 6.7 | 8.6 | · | 8.3 | 10.5 | 13.1 | · | 10.0 | 8.7 | 10.6 | · | 12.1 | 10.9 | 13.8 | · | 15.6 | |
| Debt / Equity | 2.9 | 2.0 | · | 1.0 | 0.9 | 0.7 | · | 0.8 | 0.5 | 0.4 | · | 0.2 | 0.2 | 0.1 | · | · | |
| LT Debt / Equity | 2.9 | 2.0 | · | 1.0 | 0.9 | 0.7 | · | 0.8 | 0.5 | 0.4 | · | 0.2 | 0.2 | 0.1 | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -23.2 | · | -19.1 | -24.4 | -50.7 | · | · |
Effizienz 3
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.0 | |
| Inventory Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.3 | |
| Receivables Turnover | 1.9 | 1.6 | · | 1.7 | 1.7 | 1.4 | · | 1.7 | 1.5 | 1.4 | · | 1.8 | 1.8 | 1.6 | · | 1.4 |
Bewertung (TTM) 14
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $59M | $55M | · | $54M | $51M | $48M | · | $46M | $43M | $39M | · | $34M | $29M | $23M | · | $19M | |
| Net Income TTM | $-55M | $-54M | · | $-54M | $-56M | $-63M | · | $-58M | $-57M | $-54M | · | $-42M | $-44M | $-42M | · | $-37M | |
| Market Cap | $137M | $250M | · | $211M | $154M | $319M | · | $213M | $260M | $393M | · | $316M | $320M | $193M | · | $192M | |
| Enterprise Value | $131M | $236M | · | $176M | $108M | $265M | · | $162M | $219M | $342M | · | $247M | $244M | $104M | · | · | |
| P/E | -2.5 | -4.5 | · | -3.7 | -2.5 | -4.4 | · | -3.3 | -4.5 | -7.1 | · | -7.5 | -7.2 | -4.5 | · | -5.2 | |
| P/S | 2.3 | 4.5 | · | 3.9 | 3.0 | 6.6 | · | 4.6 | 6.1 | 10.1 | · | 9.2 | 11.2 | 8.3 | · | 10.3 | |
| P/B | 6.9 | 8.6 | · | 4.4 | 2.7 | 4.6 | · | 3.3 | 4.7 | 5.9 | · | 3.8 | 3.6 | 1.9 | · | 1.6 | |
| P / Tangible Book | 6.9 | 8.6 | · | 4.4 | 2.7 | 4.6 | · | 3.3 | 4.7 | 5.9 | · | 3.8 | 3.6 | 1.9 | · | 1.6 | |
| P / Cash Flow | · | -20.6 | · | · | · | -25.0 | · | · | · | -36.1 | · | · | · | -18.8 | · | · | |
| P / FCF | · | -20.3 | · | · | · | -24.7 | · | · | · | -33.3 | · | · | · | -18.4 | · | · | |
| EV / EBITDA | -10.1 | -19.4 | · | -14.3 | -7.5 | -19.7 | · | -12.5 | -15.7 | -15.4 | · | -25.9 | -20.7 | -8.5 | · | · | |
| EV / FCF | · | -19.2 | · | · | · | -20.6 | · | · | · | -29.0 | · | · | · | -9.9 | · | · | |
| EV / Revenue | 2.2 | 4.3 | · | 3.3 | 2.1 | 5.5 | · | 3.5 | 5.1 | 8.8 | · | 7.2 | 8.5 | 4.5 | · | · | |
| Earnings Yield | -40.7% | -22.1% | · | -26.8% | -39.5% | -22.8% | · | -30.5% | -22.4% | -14.2% | · | -13.3% | -13.8% | -22.1% | · | -19.4% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | $57M | $51M | $39M | $22M | $13M |
| Bruttogewinnmarge % | 85.3% | 83.8% | 84.1% | 77.8% | 72.1% |
| Betriebsgewinnmarge % | -90.5% | -116.0% | -109.7% | -189.3% | -199.2% |
| Nettoergebnis | $-53M | $-60M | $-41M | $-41M | $-43M |
| Verwässerte EPS | $-2.04 | $-2.65 | $-1.99 | $-2.02 | $-4.16 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 1.3 | 0.7 | 0.4 | 0.1 | 0.0 |
| Liquiditätsgrad | 7.6 | 12.1 | 14.3 | 15.2 | 25.6 |
| Quick Ratio | 6.5 | 10.7 | 12.5 | 13.8 | 24.5 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $-41M | $-41M | $-40M | $-43M | $-29M |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 100 Einreicher · $63.2M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 13 (-11 vs. Vorquartal) | 17 (+4 vs. Vorquartal) | 28 (-1 vs. Vorquartal) | 29 (+8 vs. Vorquartal) | +2K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| JOHNSON & JOHNSON | $20.687.786 | 4.024.861 | 32,73% | Aktien |
| NEA Management Company, LLC | $10.045.822 | 1.954.440 | 15,89% | Aktien |
| GSK plc | $5.178.977 | 1.007.583 | 8,19% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $4.680.361 | 910.576 | 7,41% | Aktien |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $4.513.480 | 878.109 | 7,14% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $1.942.206 | 377.698 | 3,07% | Aktien |
| PFM Health Sciences, LP | $1.899.600 | 369.572 | 3,01% | Aktien |
| STATE STREET CORP | $1.883.049 | 366.352 | 2,98% | Aktien |
| Nuveen Asset Management, LLC | $1.471.114 | 116.110 | 2,33% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $1.182.200 | 230.000 | 1,87% | Aktien |
| TUDOR INVESTMENT CORP ET AL | $1.057.216 | 205.684 | 1,67% | Aktien |
| Kestra Advisory Services, LLC | $680.536 | 132.400 | 1,08% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $680.526 | 132.398 | 1,08% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $662.829 | 128.955 | 1,05% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $544.403 | 105.915 | 0,86% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $543.704 | 105.779 | 0,86% | Aktien |
| Cresset Asset Management, LLC | $533.784 | 103.849 | 0,84% | Aktien |
| AlphaQuest LLC | $502.645 | 70.795 | 0,80% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $500.168 | 97.309 | 0,79% | Aktien |
| Quantinno Capital Management LP | $423.192 | 82.333 | 0,67% | Aktien |
| CITADEL ADVISORS LLC | $271.844 | 52.888 | 0,43% | Aktien |
| Nuveen, LLC | $254.666 | 49.546 | 0,40% | Aktien |
| WOLVERINE TRADING, LLC | $228.312 | 29.346 | 0,36% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $220.986 | 23.360 | 0,35% | Aktien |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $210.226 | 40.900 | 0,33% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $181.946 | 35.398 | 0,29% | Aktien |
| Point72 Asset Management, L.P. | $137.613 | 26.773 | 0,22% | Aktien |
| XTX Topco Ltd | $112.181 | 21.825 | 0,18% | Aktien |
| Jain Global LLC | $109.482 | 21.300 | 0,17% | Aktien |
| Mitsubishi UFJ Asset Management Co., Ltd. | $106.532 | 20.726 | 0,17% | Aktien |
| RBF Capital, LLC | $102.800 | 20.000 | 0,16% | Aktien |
| BANK OF AMERICA CORP /DE/ | $102.085 | 19.861 | 0,16% | Aktien |
| RHUMBLINE ADVISERS | $96.688 | 18.812 | 0,15% | Aktien |
| Corton Capital Inc. | $85.461 | 10.590 | 0,14% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $84.476 | 16.435 | 0,13% | Aktien |
| Graham Capital Management, L.P. | $76.884 | 14.958 | 0,12% | Aktien |
| CWM, LLC | $76.238 | 8.059 | 0,12% | Aktien |
| WELLS FARGO & COMPANY/MN | $71.986 | 14.005 | 0,11% | Aktien |
| JPMORGAN CHASE & CO | $71.613 | 12.056 | 0,11% | Aktien |
| JANE STREET GROUP, LLC | $69.390 | 13.500 | 0,11% | Kaufoption |
| UBS Group AG | $69.118 | 13.447 | 0,11% | Aktien |
| R Squared Ltd | $68.907 | 13.406 | 0,11% | Aktien |
| Arax Advisory Partners | $67.689 | 13.169 | 0,11% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $59.588 | 11.593 | 0,09% | Aktien |
| CITADEL ADVISORS LLC | $58.596 | 11.400 | 0,09% | Kaufoption |
| GOLDMAN SACHS GROUP INC | $55.836 | 10.863 | 0,09% | Aktien |
| Centiva Capital, LP | $55.065 | 10.713 | 0,09% | Aktien |
| MERCER GLOBAL ADVISORS INC /ADV | $44.255 | 8.610 | 0,07% | Aktien |
| Bank of New York Mellon Corp | $42.909 | 8.348 | 0,07% | Aktien |
| VANGUARD GROUP INC | $41.329 | 5.821 | 0,07% | Aktien |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $36.340 | 7.070 | 0,06% | Aktien |
| WHITTIER TRUST CO | $33.780 | 6.000 | 0,05% | Aktien |
| CITIGROUP INC | $32.469 | 6.317 | 0,05% | Aktien |
| BlackRock, Inc. | $32.074 | 6.240 | 0,05% | Aktien |
| Vanguard Global Advisers, LLC | $29.920 | 5.821 | 0,05% | Aktien |
| NISA INVESTMENT ADVISORS, LLC | $29.031 | 5.648 | 0,05% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $21.557 | 4.194 | 0,03% | Aktien |
| Police & Firemen's Retirement System of New Jersey | $19.378 | 3.770 | 0,03% | Aktien |
| HighMark Wealth Management LLC | $15.420 | 3.000 | 0,02% | Aktien |
| CAROLINAS WEALTH CONSULTING LLC | $15.127 | 1.237 | 0,02% | Aktien |
| NORTHERN TRUST CORP | $11.282 | 2.195 | 0,02% | Aktien |
| BARCLAYS PLC | $10.999 | 2.140 | 0,02% | Aktien |
| Tower Research Capital LLC (TRC) | $9.648 | 1.877 | 0,02% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $8.221 | 869 | 0,01% | Aktien |
| Legal & General Group Plc | $7.134 | 1.388 | 0,01% | Aktien |
| GAMMA Investing LLC | $5.392 | 1.049 | 0,01% | Aktien |
| JNBA Financial Advisors | $5.140 | 1.000 | 0,01% | Aktien |
| JONES FINANCIAL COMPANIES LLLP | $4.911 | 838 | 0,01% | Aktien |
| Ameritas Investment Partners, Inc. | $4.719 | 918 | 0,01% | Aktien |
| Jump Financial, LLC | $2.570 | 500 | 0,00% | Aktien |
| GROUP ONE TRADING LLC | $2.174 | 423 | 0,00% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $2.077 | 404 | 0,00% | Aktien |
| ROYAL BANK OF CANADA | $2.000 | 467 | 0,00% | Aktien |
| FMR LLC | $1.789 | 348 | 0,00% | Aktien |
| OSAIC HOLDINGS, INC. | $1.542 | 300 | 0,00% | Aktien |
| Archer Investment Corp | $1.285 | 250 | 0,00% | Aktien |
| THURSTON, SPRINGER, MILLER, HERD & TITAK, INC. | $1.156 | 225 | 0,00% | Aktien |
| DEUTSCHE BANK AG\ | $1.121 | 218 | 0,00% | Aktien |
| PROEQUITIES, INC. | $1.032 | 60 | 0,00% | Aktien |
| Russell Investments Group, Ltd. | $971 | 189 | 0,00% | Aktien |
| True Wealth Design, LLC | $895 | 174 | 0,00% | Aktien |
| Allworth Financial LP | $736 | 143 | 0,00% | Aktien |
| ROTHSCHILD INVESTMENT LLC | $493 | 96 | 0,00% | Aktien |
| Caitong International Asset Management Co., Ltd | $350 | 68 | 0,00% | Aktien |
| GSA CAPITAL PARTNERS LLP | $259 | 50.358 | 0,00% | Aktien |
| Integrated Wealth Concepts LLC | $225 | 44 | 0,00% | Aktien |
| SJS Investment Consulting Inc. | $222 | 43 | 0,00% | Aktien |
| Sunbelt Securities, Inc. | $208 | 22 | 0,00% | Aktien |
| Farther Finance Advisors, LLC | $191 | 37 | 0,00% | Aktien |
| Sterling Capital Management LLC | $185 | 36 | 0,00% | Aktien |
| Versant Capital Management, Inc | $180 | 35 | 0,00% | Aktien |
| EverSource Wealth Advisors, LLC | $149 | 29 | 0,00% | Aktien |
| Clearstead Advisors, LLC | $125 | 24 | 0,00% | Aktien |
| IFP Advisors, Inc | $93 | 18 | 0,00% | Aktien |
| SBI Securities Co., Ltd. | $87 | 17 | 0,00% | Aktien |
| PHILADELPHIA TRUST CO | $77 | 15.000 | 0,00% | Aktien |
| MORGAN STANLEY | $67 | 13 | 0,00% | Aktien |
| PRICE T ROWE ASSOCIATES INC /MD/ | $62 | 12.051 | 0,00% | Aktien |
| Essential Partners LLC | $41 | 8 | 0,00% | Aktien |
| PNC Financial Services Group, Inc. | $36 | 7 | 0,00% | Aktien |
Unternehmensinsider 21 Insider · 6 Führungskräfte · 2 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Nadim Yared | Chief Executive Officer | 3. Februar 2022 M | 21.276 | 0 | 0 | $0 |
| Jared Oasheim | Chief Financial Officer | 18. Januar 2022 A | — | 0 | 0 | $0 |
| Dean Bruhn-Ding | VP of Reg. Affairs and QA | 8. Februar 2022 M | 54.648 | 0 | 0 | $0 |
| Paul Verrastro | Chief Marketing Officer | 18. Januar 2022 A | — | 0 | 0 | $0 |
| Liz Galle | VP of Global Clinical Research | 18. Januar 2022 A | — | 0 | 0 | $0 |
| John Brintnall | Chief Strategy Officer and Sec | 30. Dezember 2021 M | 10.450 | 0 | 0 | $0 |
| Ali Behbahani | Direktor | 4. Juni 2024 A | 316 | 0 | 0 | $0 |
| Johnson & Johnson Innovation - JJDC, Inc. | 10%-Eigentümer | 15. September 2023 J | 0 | 0 | 0 | $0 |
| New Enterprise Associates 10, Limited Partnership | 10%-Eigentümer | 2. Juli 2021 C | 2.026.083 | 0 | 0 | $0 |
| Brent Binkowski | — | 13. August 2026 P | 56.514 | 1 | 1 | $72.971 |
| Martha Shadan | — | 1. Juni 2026 A | 8.720 | 0 | 0 | $0 |
| Mitch C. Hill, | — | 1. Juni 2026 A | 8.720 | 0 | 0 | $0 |
| Mudit K. Jain | — | 1. Juni 2026 A | 14.370 | 0 | 0 | $0 |
| Kevin J. Ballinger | — | 1. Juni 2026 A | 8.720 | 0 | 0 | $0 |
| Kirk Nielsen | — | 1. Juni 2026 A | 8.720 | 0 | 0 | $0 |
| Joseph P Slattery | — | 1. Juni 2026 A | 39.365 | 0 | 0 | $0 |
| DALE MICHAEL D | — | 1. Juni 2026 A | 29.005 | 0 | 0 | $0 |
| Gregory Morrison | — | 2. März 2026 A | 34.000 | 0 | 0 | $0 |
| Geoffrey B Pardo | — | 2. Juli 2021 C | 1.829.022 | 0 | 0 | $0 |
| GSK plc | — | 2. Juli 2021 C | 1.007.583 | 0 | 0 | $0 |
| John M Nehra | — | 2. Juli 2021 P | 28.266 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 3 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| New Enterprise Associates 10, Limited Partnership, New Enterprise Associates 8A, Limited Partnership, NEA Partners 10, Limited Partnership, New Enterprise Associates VIII, Limited Partnership, NEA Partners VIII, Limited Partnership, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Scott D. Sandell | 20. Februar 2025 | 7,80% | Änderung | — | SEC |
| Cooperatieve Gilde Healthcare IV U.A., Gilde Healthcare IV Management B.V., Gilde Healthcare Holding B.V., Manapouri B.V., Martemanshurk B.V. ×4 Einreichungen | 6. Februar 2025 | 4,90% | Änderung | — | SEC |
| New Enterprise Associates 8A, Limited Partnership, New Enterprise Associates 10, Limited Partnership, NEA Partners 10, Limited Partnership, New Enterprise Associates VIII, Limited Partnership, NEA Partners VIII, Limited Partnership, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Scott D. Sandell ×2 Einreichungen | 7. November 2024 | — | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 21 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IWC · iShares Trust | 0,02% | 51.597 SH | 8. August 2026 | Täglich |
| IWO · iShares Trust | 0,01% | 152.223 SH | 8. August 2026 | Täglich |
| RSSL · Global X Funds | 0,00% | 7.117 NS | 30. April 2026 | N-PORT |
| IWM · iShares Trust | 0,00% | 364.103 SH | 8. August 2026 | Täglich |
| ITWO · ProShares Trust | 0,00% | 758 NS | 31. Mai 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 41.696 NS | 30. April 2026 | N-PORT |
| UWM · ProShares Trust | 0,00% | 591 NS | 31. Mai 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 595 NS | 31. Mai 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 577 NS | 31. Mai 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 15 NS | 31. Mai 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 1.354 NS | 30. April 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 5.239 SH | 8. August 2026 | Täglich |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,00% | 358 NS | 31. Mai 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 5.367 NS | 30. April 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 204.533 SH | 8. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 684.121 SH | 8. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 89.003 SH | 8. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 15.722 SH | 8. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 1.190 SH | 8. August 2026 | Täglich |
| EBI · RBB Fund Trust | 0,00% | 22 NS | 31. Mai 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 4 NS | 30. April 2026 | N-PORT |